sexual behavior (PSB) have noted select clinical and neurocognitive differences relative to other patient populations and healthy controls, but neurocognitive findings have varied. This analysis assesses the clinical presentation and neurocognitive profile of patients with PSB relative to those with no sexual problems. Methods: 492 participants (18-29) were recruited for a study on impulsivity in young adults. Participants completed diagnostic, self-report, and neurocognitive measures which assessed impulsivity, cognitive flexibility, decision making, and spatial working memory. PSB was defined as endorsing fantasies, urges, or sexual behavior that felt out of control or was causing distress. Summary: 54 (11%) participants reported current PSB. This group was older, reported earlier first sexual experiences and earlier alcohol use, and lower quality of life and self-esteem. Comorbidity rates were higher in the PSB group, particularly for depression and alcohol dependence. The PSB group differed across cognitive measures related to impulsivity, decision making, spatial working memory, problem solving, and emotional dysregulation. Conclusions: These findings suggest that PSB is associated with numerous problems, including psychosocial dysfunction, higher comorbidity rates, and deficits in several neurocognitive domains. These associations appear to extend beyond those directly related to sex or sexual health, suggesting a more salient impact on wellbeing and functioning. Furthermore, this study demonstrated several neurocognitive deficits in the PSB group, features which have found only mixed support in previous studies. These cognitive differences may be particularly notable for clinicians treating patients with PSB, as it may be possible to tailor treatment options to address these unique features of PSB relative to other patient populations.
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SLEEP DISORDERS: PT650 -PT666 PT650
Genome-wide association study identifies novel susceptible locus rs9390170 on 6q24 for restless legs syndrome in a Korean population. , Leen Kim population dataset from the Korea Association Resource (KARE) project collected the Ansung and Ansan cohorts. We conducted a GWAS for RLS symptom group (n=325) which has at least one of 4 basic criteria of RLS and controls (n=2,603) using 352,228 SNPs. We observed rs11645604 (odds ratio = 1.531; P = 1.18 x 10 -6 ) in MPHOSPH6 on chromosome 16q23.3, rs1918752 (odds ratio = 0.6582; P = 1.93 x 10 -6 ) and rs9390170 (odds ratio = 0.6778; P = 7.67 x 10 -6 ) in UTRN on chromosome 6q24. And we performed a replication study in our own RLS sample to reconfirm our GWAS finding as well as previous GWAS results. We selected several candidate SNPs in MPHOSPH6 and UTRN according to our GWAS results, as well in MEIS1, BTBD9, and PTPRD according to previous GWAS results. We found the most significant of which was rs9390170 in UTRN (odds ratio = 1.6121; P = 0.0379) in the recessive model and rs3923809 in BTBD9 (odds ratio = 1.3136; P = 0.044) in the allele model from case-control association analysis on 228 RLS cases and 229 controls. And rs6710341/ rs2300478 in MEIS1 showed significant finding (overall P = 1.15 x 10 -6
; permutation P = 0) from case-control haplotype analysis. In this study, we reconfirmed rs3923809 in BTBD9 and rs6710341/ rs2300478 in MEIS1 as significant sequence variations contributing RLS. In addition, we found the possibility of novel sequence variation which is rs9390170 in UTRN. UTRN encodes dystrophin-related protein 1, and its known function is related to neuromuscular system. Keyword: genome-wide association study, restless legs syndrome, replication study, UTRN
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The role of Ca2+-dependent hyperpolarization pathway underlying sleep homeostasis 
Abstract
Since sleep disorders relate to most of psychiatric disorders (e.g. Schizophrenia, Bipolar disorder, and Depression), the understanding of mechanisms of sleep can apply not only to the treatment of sleep disorders and also to the treatment of psychiatric disorders. Although there are numerous researches about sleep and sleep disorders, the detailed molecular mechanisms underlying sleep-time regulation in mammals are still elusive. In our recent study, we combined a simple computational model of an averaged neuron, the developed triple-target CRISPR method, and the non-invasive sleep/wake recording system SSS (Ref.1) to comprehensively generate and analyze more than 20 KO mice, which validated 8 molecules whose impairment can change the sleep time in mice and also posed a possibility that a Ca2+-dependent hyperpolarization pathway underlies sleep-time regulation in mammals. Here, we further analyzed the Ca2+-dependent hyperpolarization pathway in the view of sleep homeostasis. Each strain of knockout mice (KO) which were impaired each gene out of 8 genes, were conducted to sleep-deprivation experiments and fluorescence in situ hybridization (FISH) analysis, in order to validate the change of sleep homeostasis and neuronal excitability between KO and wild-type mice. According to these experiments, we revealed the role of Ca2+-dependent hyperpolarization pathway underlying sleep homeostasis Ref.1: Sunagawa, G.A., et al., 2016, Cell Reports 14, 662-677. 
